Insider Purchases: Inside the Buy
Tag: FUNstock Index
The “WTW” Strategy Scorecard: Why the Smart Money Is Huddled Here
Willis Towers Watson isn’t a hype stock—it’s a fortress. With insider buying, 100%+ institutional ownership, surging margins, and massive buybacks, WTW is quietly becoming one of the smartest “sleep-well” investments of 2026.
CHRW 2026: The “Karaoke Crash” and the Many Insiders “Buy-The-Dips”
A tiny “AI logistics” headline sparked a selloff in C.H. Robinson (CHRW). Insiders responded by buying. Is this a fear-driven dip or a signal that Lean AI is turning logistics into a margin machine?
Monro’s Pivot: From Aggressive Expansion to Margin Optimization
Monro cut 145 underperforming stores, lifted margins, and still pays a 5.5% dividend—while the CEO and Carl Icahn buy shares. A slow-burn, high-yield turnaround story in an aging-car economy.
Lumen Technologies: The Turnaround Nobody Believed (But the CEO Keeps Adding)
Lumen was left for dead—then the CEO kept buying, debt vanished, and AI demand showed up. A fun, honest look at LUMN’s comeback, risks, and why the stock may need a breather before the next sprint.
Enphase Energy: The Comeback Nobody Believed (But the CEO Keeps Buying)
Enphase Energy fell hard after its solar boom—but the CEO keeps buying, institutions still dominate the float, and shorts are piled in. Here’s why ENPH might be starting to sync back in—and what investors should really watch. 🌞🔋
CEO Purchases Abbott Shares, But the Stock Carries Risks
Abbott’s CEO just stepped in with a $2M insider buy — analysts are bullish, shorts are scarce, and institutions remain locked in. Tempting? Yes. Risk-free? Not quite.
CEO and COO Buy Shares of RLI — Exceptionally Run Insurer, but Not Without Storm Clouds
RLI Corp is exceptionally well run, with insider buying and 30 years of underwriting profits — but forward valuation and catastrophe risk argue for patience, not haste.
CEO Buys More of This Warren Buffett Favorite: Ally Financial Is Up 30% Since Our Bullish Call — Buy More?
Ally Financial is up nearly 30% since our bullish call — and the CEO just bought almost $1M more stock. With Buffett still onboard, analysts bullish, and valuation cheap, this value story may not be done.
Ryan Cohen Buys More GameStop; Time to Play — or Make This Story Short?
Ryan Cohen doubles down on GameStop. Shorts stay crowded. Analysts stay bearish. But profits, cash, and conviction are back. Is GME still a meme — or a mispriced turnaround? 🎯🎮
Insider Buys Shares of Mainz Biomed: Promising Science, Precarious Finances
Mainz Biomed’s cancer-screening science is compelling — and an insider just bought big. But with heavy losses, dilution risk, and a going-concern warning, MYNZ is a biotech moonshot best approached with extreme caution.